Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

Completed · Phase 4

Conditions studied: Hematological Malignancies

In brief

Primary Objectives: 1. To determine whether aerosolized ribavirin is effective when given at an intermittent dose over 3 hours every 8 hours for therapy of RSV upper respiratory tract infection (URI) and whether it can prevent progression to pneumonia. 2. To determine the effect of this regimen on persistence of viral shedding.

Key facts

Study ID

NCT00500578

Run by

M.D. Anderson Cancer Center

People needed

51

Starts

2003-02-01

Expected to finish

2009-01-01

Last updated by the study team

2012-08-01

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with these underlying malignancies will be eligible for this study: Autologous BMT patients, Allogeneic BMT patients, and patients with hematological malignancy.
• Patients must be at least 5 years of age.
• Only patients with infection limited to the URT will be eligible for entry on study
• Patients will be eligible for entry on study if a nasopharyngeal wash or throat swab specimen is positive by rapid RSV antigen testing or by a positive culture for RSV.

You may not qualify if…

• Patients with evidence of RSV LRTI as documented by a positive rapid RSV antigen testing or by a positive culture for RSV from a nasopharyngeal wash or throat swab AND new infiltrates on chest radiograph and/or abnormal blood gas determination
• Patients with hypersensitivity to ribavirin or its components
• Pregnant women. Participants must practice birth control during the study if they are sexually active. If the participant is pregnant, she may not be enrolled on this study. Mothers should refrain from breast-feeding during the study to avoid injury to their children.
• Patients with positive RSV by rapid testing or culture in bronchoalveolar lavage regardless of the chest radiographic results.

Where it is running

• U.T.M.D. Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.